Ganesh and Jayaraman
) 8:2) to afford 8 (0.027 g, 79%) as a colorless oil. Rf 0.30 (5:1
MHz, CDCl3) δ 152.2, 138.2, 137.9, 137.7, 136.9, 128.4, 128.3,
128.1, 128.0, 127.6, 127.5, 120.2, 102.0, 79.3, 76.7, 73.4, 73.3,
71.1, 70.1, 57.1; HRMS m/z C36H37ClO6Na calcd 623.2176, found
623.2153.
1
hexane/EtOAc); [R]D +19 (c 1.00, CHCl3); H NMR (400 MHz,
CDCl3) δ 7.45-7.14 (m, 15H), 4.86 (d, J ) 10.4 Hz, 1H), 4.78 (d,
J ) 13.6, 2H), 4.59-4.51 (m, 3H), 4.45-4.32 (m, 3H), 3.80-
3.62 (m, 3H), 3.45 (s, 3H), 3.36 (d, J ) 7.6 Hz, 1H), 2.6 (br s,
1H); 13C NMR (100 MHz, CDCl3) δ 204.3, 137.8, 137.1, 137.0,
128.6, 128.5, 128.4, 128.3, 128.0, 127.9, 127.8, 127.7, 104.1, 88.7,
78.3, 76.3, 75.2, 73.4, 73.2, 70.2, 70.1, 56.4; HRMS m/z calcd
C29H32O7Na 515.2046, found 515.2025.
Methyl 4,5,7-tri-O-benzyl-R-D-lyxo-sept-2,3-diuloside (14). To
a stirred solution of chloro-oxepine 13 (0.090 g, 0.150 mmol) in
MeCN:CCl4 (5 mL, 1:1) at 0 °C was added a solution of RuCl3
(cat.) and NaIO4 (0.080 g, 0.375 mmol) in water (2 mL) dropwise.
After 8 h of stirring at room temperature, the reaction mixture was
diluted with EtOAc (10 mL) and CH2Cl2 (10 mL), filtered through
a pad of silica gel, and washed with EtOAc (2 × 20 mL) and the
solvents were removed in vacuo. The resulting residue was purified
(hexane:EtOAc ) 7:3) to afford 14 (0.055 g, 75%), in the hydrated
form, as a colorless oil. Rf 0.48 (1:1 hexane/EtOAc); [R]D +20 (c
1.00, CH2Cl2); 1H NMR (400 MHz, CDCl3) δ 7.42-7.21 (m, 15H),
5.16 (s, 1H), 4.95-4.89 (m, 2H), 4.73-4.67 (m, 2H), 4.54 (d, J )
11.3 Hz, 1H), 4.47 (d, J ) 11.3 Hz, 1H), 4.40 (d, J ) 7.1 Hz, 1H),
4.36 (m, 1H), 4.15-4.10 (m, 1H), 3.56-3.49 (m, 2H), 3.48 (s,
3H); 13C NMR (100 MHz, CDCl3) δ 203.0, 137.6, 137.4, 137.0,
128.7, 128.6, 128.5, 128.4, 128.1, 128.0, 127.9, 127.8, 127.7, 127.6,
100.6, 93.2, 85.0, 77.8, 74.4, 73.5, 71.2, 68.7, 56.8; HRMS m/z
C29H30O7Na‚H2O calcd 531.1995, found 531.2003.
Methyl 4,5,7-tri-O-benzyl-R-D-glycero-L-altro-septanoside (15).
To a solution of 14 (0.050 g, 0.102 mmol) in MeOH (4 mL) at
0 °C was added NaBH4 (0.019 g, 0.510 mmol), then the mixture
was stirred for 2 h, solvents were removed in vacuo, the resulting
residue was dissolved with EtOAc (3 × 15 mL), washed with brine
(10 mL), dried (Na2SO4), and concentrated in vacuo, and the crude
product was purified (hexane:EtOAc ) 6:4) to afford 15 (0.042 g,
83%) as a colorless oil. Rf 0.39 (1:1 hexane/EtOAc); [R]D +29 (c
1.00, CH2Cl2); 1H NMR (400 MHz, CDCl3) δ 7.49-7.26 (m, 15H),
5.02 (d, J ) 11.5 Hz, 1H), 4.85 (d, J ) 3.9 Hz, 1H), 4.78 (d, J )
11.7 Hz, 1H), 4.63-4.57 (m, 2H), 4.50-4.48 (m, 1H), 4.44-4.34
(m, 2H), 4.27-4.24 (dd, J ) 6.7, 3.9 Hz, 1H), 4.15-4.07 (m, 2H),
3.99-3.98 (m, 2H), 3.51-3.47 (m, 1H), 3.45 (s, 3H), 3.42-3.38
(m, 1H), 2.78 (br s, 1H); 13C NMR (100 MHz, CDCl3) δ 138.4,
138.0, 129.9, 128.7, 128.5, 127.9, 127.7, 99.1, 79.3, 77.8, 75.7,
73.4, 73.1, 71.8, 71.7, 69.8, 69.6, 55.7; HRMS m/z C29H34O7Na
calcd 517.2202, found 517.2211.
Methyl 4,5,7-tri-O-benzyl-R-D-glycero-D-talo-septanoside (9).
To a solution of 8 (0.027 g, 0.055 mmol) in MeOH (2 mL) was
added NaBH4 (0.010 g, 0.274 mmol) at 0 °C then the solution was
stirred for 2 h, solvents were removed in vacuo, and the resulting
residue was dissolved in EtOAc (3 × 10 mL) and washed with
brine (10 mL). The combined organic extracts were dried (Na2-
SO4) and concentrated in vacuo and purified (hexane:EtOAc ) 1:1)
to afford 9 (0.021 g, 77%) as a colorless oil. Rf 0.26 (1:1 hexane/
1
EtOAc); [R]D +32 (c 1.00, CHCl3); H NMR (400 MHz, CDCl3)
δ 7.35-7.16 (m, 15H), 4.76 (d, J ) 11.3 Hz, 1H), 4.73 (d, J ) 5.6
Hz, 1H), 4.69 (s, 2H), 4.59 (d, J ) 11.5 Hz, 1H), 4.52-4.48 (m,
2H), 4.2 (br s, 1H), 3.86 (d, J ) 3.6 Hz, 2H), 3.72-3.68 (m, 3H),
3.63-3.61 (m, 1H), 3.43 (s, 3H), 2.84 (br s, 1H), 2.56 (br s, 1H);
13C NMR (100 MHz, CDCl3) δ 138.1, 138.0, 137.6, 128.5, 128.4,
128.3, 128.0, 127.7, 127.6, 102.7, 85.3, 77.2, 74.6, 74.5, 73.3, 73.1,
71.6, 71.1, 70.6, 56.0; HRMS m/z C29H34O7Na calcd 517.2202,
found 517.2214.
Methyl R-D-glycero-D-talo-Septanoside (10). To a solution of
9 (0.020 g, 0.040 mmol) in MeOH (15 mL) was added Pd/C (10%,
0.030 g), then the solution was stirred at room temperature under
a pressure of hydrogen gas for 10 h. The reaction mixture was
filtered over a celite pad and washed with MeOH (3 × 15 mL),
and solvents were removed in vacuo to afford 10 (0.008 g, 89%)
as a colorless oil. Rf 0.58 (1:1 CH3OH/ CHCl3); [R]D +51 (c 1.00,
1
CH3OH); H NMR (500 MHz, D2O) δ 4.52 (d, J ) 6.5 Hz, 1H),
3.97 (d, J ) 1.5 Hz, 1H), 3.78-3.76 (m, 2H), 3.64 (dd, J ) 13.5,
3.5 Hz, 1H), 3.58-3.49 (m, 3H), 3.41(s, 3H); 13C NMR (125 MHz,
D2O) δ 102.6, 76.3, 76.0, 72.1, 71.5, 70.3, 62.0, 55.6; HRMS m/z
C8H16O7Na calcd 247.0794, found 247.0794.
1,5-Anhydro-2,3,4,6-tetra-O-benzyl-1,2-C-(dichloromethylene)-
R-D-glycero-L-altro-hexitol (12). To a stirred solution of oxygalactal
1111 (0.198 g, 0.327 mmol) and benzyltriethylammonium chloride
(cat.) in CHCl3 (1 mL) was added aq NaOH (50%, 1.1 mL)
dropwise at room temperature, then the solution was stirred at 40
°C for 2 h, diluted with brine (20 mL), extracted with CH2Cl2 (3
× 20 mL), dried (Na2SO4), and concentrated in vacuo, and the
resulting residue was purified (hexane:EtOAc ) 9:1) to afford 12
(0.195 g, 85%) as a colorless oil. Rf 0.64 (9:1 hexane/EtOAc); [R]D
Methyl R-D-glycero-L-altro-Septanoside (16). To a stirred
solution of 15 (0.040 g, 0.081 mmol) in MeOH (20 mL) was added
Pd/C (10%, 0.023 g) with continued stirring at room temperature
under a pressure of hydrogen gas for 12 h. The reaction mixture
was then filtered through a celite pad and washed with MeOH (3
× 15 mL), and solvents were removed in vacuo to afford 16 (0.016
g, 91%) as a colorless oil. Rf 0.45 (1:1 CH3OH/CHCl3); [R]D +54
(c 1.00, CH3OH); 1H NMR (500 MHz, D2O) δ 4.73 (d, J ) 3 Hz,
1H), 4.0 (dd, J ) 6.5, 3 Hz, 1H), 3.97-3.95 (m, 1H), 3.90-3.86
(m, 3H), 3.58-3.55 (dd, J ) 11.5, 7 Hz, 1H), 3.54-3.50 (dd, J )
11.5, 5.5 Hz, 1H), 3.34 (s, 3H); 13C NMR (125 MHz, D2O) δ 100.1,
74.5, 73.2, 71.9, 71.5, 69.3, 61.7, 55.8; HRMS m/z C8H16O7Na calcd
247.0794, found 247.0793.
1
+9 (c 1.00, CH2Cl2); H NMR (300 MHz, CDCl3) δ 7.36-7.17
(m, 20H), 5.03-4.97 (m, 3H), 4.68-4.56 (m, 3H), 4.48-4.36 (m,
2H), 4.08 (d, J ) 2.1 Hz, 1H), 3.95 (s, 1H), 3.92-3.90 (m, 2H),
3.57-3.47 (m, 2H); 13C NMR (75 MHz, CDCl3) δ 138.3, 138.1,
138.0, 128.8, 128.7, 128.5, 128.4, 128.2, 127.8, 77.8, 75.5, 74.4,
73.9, 73.8, 72.3, 71.2, 69.2, 67.2, 63.2, 62.3; HRMS m/z C35H34-
Cl2O5Na calcd 627.1681, found 627.1679.
Acknowledgment. We thank NMR Research Center, IISc,
Bangalore, for their assistance to record 2-D NMR spectra. We
are grateful to Department of Science and Technology, New
Delhi, for financial support. N.V.G. thanks the Council of
Scientific and Industrial Research, New Delhi, for a research
fellowship.
Methyl 2-chloro-2-deoxy-3,4,5,7-tetra-O-benzyl-R-D-lyxo-hept-
2-enoseptanoside (13). To a stirred solution of 12 (0.102 g, 0.168
mmol) in dioxane (5 mL) was added NaOMe/CH3OH (0.5 M, 2
mL), then the reaction mixture was refluxed for 48 h and solvents
were removed in vacuo. The resulting residue was extracted with
CH2Cl2 (3 × 20 mL), washed with brine (20 mL), dried (Na2SO4),
concentrated in vacuo, and purified (hexane:EtOAc ) 9:1) to afford
13 (0.101 g, 95%) as a colorless oil. Rf 0.47 (9:1 hexane/EtOAc);
[R]D -39 (c 1.00, CH2Cl2); 1H NMR (400 MHz, CDCl3) δ 7.42-
7.19 (m, 20H), 5.18 (s, 1H), 4.84 (d, J ) 2.4 Hz, 2H), 4.78 (d, J
) 11.7 Hz, 1H), 4.63-4.41 (m, 6H), 4.30-4.26 (m, 1H), 3.90 (d,
J ) 3.0 Hz, 1H), 3.78-3.70 (m, 2H), 3.46 (s, 3H); 13C NMR (100
Supporting Information Available: General experimental
1
procedure and H and 13C NMR spectra of all new compounds.
This material is available free of charge via the Internet at
JO070444E
5504 J. Org. Chem., Vol. 72, No. 15, 2007